We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

99 hedge funds and large institutions have $749M invested in Lexicon Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 35 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 103 → 99 (-4)

8% less capital invested

Capital invested by funds: $813M → $749M (-$63.6M)

26% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 35

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

Holders
99
Holders Change
-4
Holders Change %
-3.88%
% of All Funds
2.85%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
26
Reduced
35
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Norges Bank
Norges Bank
Norway
+$3.89M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.01M
3
UBS AM
UBS AM
Illinois
+$750K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$265K
5
Morgan Stanley
Morgan Stanley
New York
+$219K

Top Sellers

1
State Street
State Street
Massachusetts
-$6.17M
2
RA
Royce & Associates
New York
-$2.07M
3
BFA
BlackRock Fund Advisors
California
-$1.47M
4
CNB
City National Bank
California
-$841K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$507K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
76
Ameritas Investment Partners
Nebraska
$29K – – –
CIBC Asset Management
77
CIBC Asset Management
Ontario, Canada
$29K – – –
PP
78
Paloma Partners
Connecticut
$29K +$28K +2,611 New
Comerica Bank
79
Comerica Bank
Texas
$24K -$28.6K -2,665 -55%
GCIA
80
Gabelli & Co Investment Advisers
New York
$24K – – –
S
81
SignatureFD
Georgia
$21K – – –
Creative Planning
82
Creative Planning
Kansas
$20K +$2K +186 +12%
ICAS
83
Investors Capital Advisory Services
Massachusetts
$19K +$18.4K +1,714 New
WAM
84
World Asset Management
Michigan
$18K -$3.4K -317 -17%
WS
85
Wedbush Securities
California
$16K – – –
LPL Financial
86
LPL Financial
California
$16K +$15.3K +1,429 New
Teacher Retirement System of Texas
87
Teacher Retirement System of Texas
Texas
$15K +$462 +43 +3%
LWM
88
Lenox Wealth Management
Ohio
$12K – – –
HI
89
Hudock Inc
Pennsylvania
$11K – – –
LTFS
90
Ladenburg Thalmann Financial Services
Florida
$10K -$10.7K -1,000 -54%
Ameriprise
91
Ameriprise
Minnesota
$10K +$516 +48 +6%
Royal Bank of Canada
92
Royal Bank of Canada
Ontario, Canada
$9K +$1.15K +107 +15%
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
$9K +$8.84K +823 New
BlackRock
94
BlackRock
New York
$8K -$1.5K -140 -16%
Northwestern Mutual Wealth Management
95
Northwestern Mutual Wealth Management
Wisconsin
$6K +$5.43K +506 +1,177%
SO
96
STRS Ohio
Ohio
$4K – – –
PNC Financial Services Group
97
PNC Financial Services Group
Pennsylvania
$1K – – –
HCM
98
Highlander Capital Management
New Jersey
$483 – – –
PI
99
Putnam Investments
Massachusetts
– -$450K -37,175 Closed
ARTA
100
A.R.T. Advisors
New York
– -$224K -18,519 Closed
1 2 3
4
5

LXRX Hedge Fund Activity: Q2 2014 in Review

99 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q2 2014, worth a combined $749M — down 7.8% from $813M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of LXRX and 8 opened new positions — a net loss of 4 holders — while 35 trimmed existing stakes and 26 added.

The largest buyer was Norges Bank, adding an estimated $3.89M. The largest seller was State Street, cutting an estimated $6.17M.

  • 99 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q2 2014, down from 103 in Q1 2014.
  • Funds reported $749M of Lexicon Pharmaceuticals stock for Q2 2014, down 7.8% quarter-over-quarter.
  • 8 funds opened new Lexicon Pharmaceuticals positions in Q2 2014 and 12 closed out, a net change of -4 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q2 2014 was Norges Bank, an estimated $3.89M added.
  • The largest Lexicon Pharmaceuticals seller in Q2 2014 was State Street, an estimated $6.17M sold.

Based on aggregated 13F filings for Q2 2014.